AstraZeneca India, Mankind Pharma sign pact to distribute asthma medicine in India
AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Control Print acquires majority stake in UK-based Codeology Group for £1 million
Expands its business in the UK market, aiming to expand its product portfolio
Glenmark ranks No.1 in dermatologist prescriptions for protective emollients and derma therapy:…
Glenmark Pharmaceuticals has been ranked number 1 in dermatologists’ prescriptions in the protective emollients category and for…
Oncology dominates CRISPR landscape: GlobalData
Oncology accounts for 30 per cent of all active CRISPR drugs
Opportunities for cell and gene therapy landscape remain high but so does challenges: GlobalData
There are 694 CGTs in development across various therapy areas in the US as of February 2024
Strides gets USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg
Gabapentin tablets will be manufactured at the company’s facility in Puducherry
ICT Mumbai’s SATHI FOUNDATION (Mumbai Biocluster) gets 60 cr to accelerate biopharma innovation
The fund will be to accelerate the development of critical therapies for diseases like cancer, rare diseases, and infectious…
High ADHD comorbidity rates offer opportunity for pipeline products to capture market: GlobalData
Among the comorbidities associated with ADHD, key opinion leaders (KOLs) interviewed by GlobalData noted anxiety disorder,…
DKSH signs distribution pact with Lactalis in Asia and Europe
Lactalis provides high-purity pharma lactose to formulate oral solid dose medicines, conforming with the lactose monohydrate…
Allecra’s EXBLIFEP approval to treat cUTIs provides valuable new weapon to tackle ESBL mediated AMR:…
In addition to the FDA approval, EXBLIFEP has also been submitted for marketing approval in the EU and received a positive opinion…
Biocon Biologics gets US market entry date for Bmab 1200, a proposed biosimilar to Stelara
Stelara (Ustekinumab) has been approved for the treatment of psoriasis, Crohn’s disease, ulcerative colitis, plaque psoriasis and…
Suven, Cohance announce merger
The merged platform to comprise three distinct business units – Pharma CDMO, Spec Chem CDMO, and API+ (inclusive of formulations)
Nezglyal remains promising therapy despite EMA’s market authorisation refusal: GlobalData
Nezglyal is a novel orally bioavailable and selective peroxisome proliferator-activated receptor (PPAR) gamma agonist that is…
FDA denial could delay launch of Minerva’s schizophrenia treatment roluperidone by at least two…
To address the clinical deficiencies stated in the CRL, Minerva must provide additional safety and efficacy data for roluperidone…
Zeno Health secures $25 million in Series C funding
Fund round was led by Korean PE investor STIC Investments and supported by existing investor Lightbox
FOPE request govt for funding to MSME to upgrade manufacturing facilities for revised Schedule M
The letter states that the said scheme may be similar to that which is for upgrading for WHO GMP
Orchid Pharma gets USFDA approval for Exblifep
Enmetazobactam is the first completely invented-in-India Beta Lactamase Inhibitor
FOPE writes to govt raising concerns about new Schedule M amendment
The new Schedule M states that manufacturing premises must be exclusively used for the production of drugs, barring any other…
VeerHealth Care plans expansion, to invest Rs 33 crores
This investment encompasses various aspects including the acquisition of land, construction of buildings, procurement of plant and…
Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell…
Takeda entered into multiple cell therapy collaborations for the development of CAR-T therapies with organizations like Memorial…